SGLT2-inhibitors: a novel class for the treatment of type 2 diabetes introduction of SGLT2-inhibitors in clinical practice. [electronic resource]
- Acta clinica Belgica
- 287-93 p. digital
Publication Type: Journal Article; Review
1784-3286
10.2143/ACB.3349 doi
Benzhydryl Compounds--therapeutic use Breast Neoplasms Canagliflozin Diabetes Mellitus, Type 2--drug therapy Female Glucose--metabolism Glucosides--therapeutic use Glycosuria--chemically induced Humans Hypoglycemia--chemically induced Hypoglycemic Agents--therapeutic use Kidney--metabolism Male Phlorhizin--therapeutic use Reproductive Tract Infections Sodium-Glucose Transporter 2 Inhibitors Thiophenes--therapeutic use Urinary Bladder Neoplasms Urinary Tract Infections